A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
Public ClinicalTrials.gov record NCT06387394. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
BOTOX® (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Study identification
- NCT ID
- NCT06387394
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 202 participants
Conditions and interventions
Conditions
Interventions
- BOTOX Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 21, 2024
- Primary completion
- Nov 24, 2025
- Completion
- Nov 24, 2025
- Last update posted
- Dec 10, 2025
2024 – 2025
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center /ID# 248218 | Birmingham | Alabama | 35205 | — |
| Mayo Clinic Arizona /ID# 248883 | Phoenix | Arizona | 85054 | — |
| Skin Care and Laser Physicians of Beverly Hills /ID# 248223 | Los Angeles | California | 90069 | — |
| Cosmetic Laser Dermatology /ID# 248215 | San Diego | California | 92121-2119 | — |
| Ava T. Shamban MD - Santa Monica. /ID# 248886 | Santa Monica | California | 90404-2208 | — |
| DMR Research PLLC /ID# 248485 | Westport | Connecticut | 06880 | — |
| Susan H. Weinkle MD /ID# 252063 | Bradenton | Florida | 34209-5642 | — |
| Skin and Cancer Associates, LLP /ID# 248209 | Miami | Florida | 33137-3254 | — |
| Coleman Center For Cosmetic Dermatologic Surgery /ID# 249827 | Metairie | Louisiana | 70006 | — |
| Delricht Research /ID# 249825 | New Orleans | Louisiana | 70115 | — |
| Clarkston Dermatology /ID# 248888 | Clarkston | Michigan | 48346 | — |
| Skin Laser and Surgery Specialists of NY and NJ /ID# 251501 | Hackensack | New Jersey | 07601-1997 | — |
| Edwin F. Williams III, MD FACS of LATHAM P.C. D/B/A THE REJUVA CENTER /ID# 248887 | Latham | New York | 12110 | — |
| Wilmington Dermatology Center /ID# 250651 | Wilmington | North Carolina | 28403 | — |
| Centricity Research Dublin Multispecialty /ID# 248484 | Dublin | Ohio | 43016 | — |
| Tennessee Clinical Research Center /ID# 248486 | Nashville | Tennessee | 37215-2885 | — |
| Bellaire Dermatology Associates /ID# 248221 | Bellaire | Texas | 77401 | — |
| Dallas Plastic Surgery Institute /ID# 248220 | Dallas | Texas | 75231 | — |
| Austin Institute for Clinical Research - Pflugerville /ID# 248217 | Pflugerville | Texas | 78660 | — |
| SkinDC /ID# 248885 | Arlington | Virginia | 22209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06387394, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 10, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06387394 live on ClinicalTrials.gov.